The Department of Veterans Affairs is launching a clinical trial to evaluate whether GLP-1 medications (Ozempic and Wegovy) can help treat alcohol use disorder in veterans. The study could inform future VA treatment options and prescribing practices if the drugs show benefit beyond their current uses.
Read full story at Federal Times →Also reported by
Related Topics
va-healthcareclinical-trialglp-1ozempicwegovyalcohol-use-disordersubstance-use-treatment